What is the immediate management of a patient presenting with symptoms of Acute Coronary Syndrome (ACS)?

Immediate Management of Acute Coronary Syndrome

All patients with suspected ACS require immediate 12-lead ECG within 10 minutes of first medical contact, aspirin 150-300 mg (non-enteric), continuous cardiac monitoring, and high-sensitivity troponin measurement, with management pathway determined by ECG findings. 1, 2

Critical First 10 Minutes

Obtain 12-lead ECG within 10 minutes to differentiate STEMI from NSTE-ACS, as this single test determines the entire treatment pathway and time-sensitive interventions. 1, 3, 2, 4

• Administer aspirin 150-300 mg immediately (non-enteric loading dose) unless contraindicated—the benefits vastly outweigh risks even if ACS is ultimately ruled out. 2, 5, 6

• Establish continuous cardiac monitoring to detect life-threatening arrhythmias, which are common in the acute phase. 3, 5

• Obtain venous access and draw blood for high-sensitivity troponin, complete blood count, metabolic panel including creatinine, and coagulation studies. 1, 3

• Assess vital signs including blood pressure in both arms (to exclude aortic dissection), heart rate, respiratory rate, and oxygen saturation. 3, 7

ECG-Driven Management Pathways

STEMI Pathway (ST-elevation or new LBBB)

Activate catheterization laboratory immediately for primary PCI with goal of reperfusion within 120 minutes of first medical contact. 1, 8, 2, 4 This is the most critical time-dependent intervention in all of cardiology.

• Administer P2Y12 inhibitor (ticagrelor 180 mg or prasugrel 60 mg preferred over clopidogrel 600 mg) as loading dose. 2, 5

• Initiate anticoagulation with unfractionated heparin, enoxaparin, bivalirudin, or fondaparinux based on institutional protocol and bleeding risk. 8, 2, 5

• If PCI cannot be achieved within 120 minutes, administer fibrinolytic therapy (alteplase, reteplase, or tenecteplase) in patients <75 years without contraindications, then transfer for angiography within 3-24 hours. 8, 4

NSTE-ACS Pathway (No ST-elevation)

Measure high-sensitivity troponin immediately and repeat at 1-2 hours (or 3-6 hours if conventional troponin assay). 1, 2, 5 The 2025 ACC/AHA guidelines emphasize that hs-cTn assays with 1-2 hour protocols provide >99.5% negative predictive value when combined with clinical assessment. 1

• Administer dual antiplatelet therapy (aspirin plus ticagrelor or clopidogrel) and anticoagulation (fondaparinux 2.5 mg SC preferred for bleeding risk profile, or enoxaparin/UFH). 3, 2, 5

• Risk stratify using clinical features: ongoing chest pain >20 minutes, hemodynamic instability, heart failure signs (S3 gallop, pulmonary rales), new mitral regurgitation murmur, elevated troponin, dynamic ST-segment changes, or GRACE score >140. 9, 3, 2

• High-risk patients require coronary angiography within 2-24 hours: immediate (<2 hours) if hemodynamically unstable, refractory ischemia, or life-threatening arrhythmias; otherwise within 24 hours. 3, 2, 5, 4

• Intermediate/low-risk patients can undergo angiography within 24-72 hours or stress testing after biomarker protocols complete. 3, 10

Essential Supportive Care

• Oxygen only if SpO2 <90% or respiratory distress—routine supplemental oxygen in normoxic patients may be harmful. 8, 3

• Morphine 2-4 mg IV for severe, refractory chest pain, but use sparingly as it may delay P2Y12 inhibitor absorption and is associated with worse outcomes in some studies. 3

• Nitroglycerin sublingual or IV for ongoing chest pain if systolic BP >90 mmHg and no right ventricular infarction (avoid in inferior STEMI until RV involvement excluded). 9

• Beta-blocker (metoprolol 25-50 mg PO) within 24 hours if no contraindications (heart failure, hypotension, bradycardia, heart block). 3

Critical Pitfalls to Avoid

Do not delay reperfusion for any reason in STEMI—every 30-minute delay increases mortality. Consultation, additional imaging, or transfer arrangements should occur simultaneously with treatment, never sequentially. 7, 4

Recognize atypical presentations, particularly in women, elderly, and diabetics who frequently present with dyspnea, nausea, fatigue, or epigastric discomfort rather than classic chest pain. 7, 4, 11 These patients have higher mortality, partly due to delayed recognition. 4

Posterior STEMI appears as ST-depression in V1-V3—obtain posterior leads (V7-V9) if suspected and treat as STEMI. 1

Do not combine fibrinolysis with immediate PCI—this "facilitated PCI" approach increases bleeding without mortality benefit. 8

Troponin elevation alone does not equal ACS—consider alternative causes including heart failure, myocarditis, pulmonary embolism, renal failure, sepsis, and demand ischemia. Clinical context is essential. 1, 3

Immediate Echocardiography Indications

Perform urgent bedside echo for hemodynamic instability, cardiogenic shock, suspected mechanical complications (acute mitral regurgitation, ventricular septal defect, free wall rupture), or when diagnosis remains uncertain despite ECG and biomarkers. 1, 3, 5 Point-of-care ultrasound by trained clinicians can identify regional wall motion abnormalities supporting ACS diagnosis or reveal alternative diagnoses like pericardial effusion or aortic dissection. 1